141 related articles for article (PubMed ID: 27027402)
1. Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism.
Xu W; Lu C; Zhang F; Shao J; Zheng S
IUBMB Life; 2016 May; 68(5):376-87. PubMed ID: 27027402
[TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
3. Dihydroartemisinin prevents liver fibrosis in bile duct ligated rats by inducing hepatic stellate cell apoptosis through modulating the PI3K/Akt pathway.
Chen Q; Chen L; Wu X; Zhang F; Jin H; Lu C; Shao J; Kong D; Wu L; Zheng S
IUBMB Life; 2016 Mar; 68(3):220-31. PubMed ID: 26865509
[TBL] [Abstract][Full Text] [Related]
4. Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions.
Yang J; Tang X; Liang Z; Chen M; Sun L
Clin Mol Hepatol; 2023 Apr; 29(2):465-481. PubMed ID: 36800698
[TBL] [Abstract][Full Text] [Related]
5. Probucol ameliorates hepatic stellate cell activation and autophagy is associated with farnesoid X receptor.
Yang R; Hu Z; Zhang P; Wu S; Song Z; Shen X; Wei Z
J Pharmacol Sci; 2019 Feb; 139(2):120-128. PubMed ID: 30638990
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of endothelin-1-mediated contraction of hepatic stellate cells by FXR ligand.
Li J; Kuruba R; Wilson A; Gao X; Zhang Y; Li S
PLoS One; 2010 Nov; 5(11):e13955. PubMed ID: 21085652
[TBL] [Abstract][Full Text] [Related]
7. Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis.
Zhang Z; Yao Z; Zhao S; Shao J; Chen A; Zhang F; Zheng S
Cell Death Dis; 2017 Jun; 8(6):e2886. PubMed ID: 28617435
[TBL] [Abstract][Full Text] [Related]
8. Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner.
Xu W; Lu C; Yao L; Zhang F; Shao J; Zheng S
Toxicol Appl Pharmacol; 2017 Jan; 315():23-34. PubMed ID: 27939985
[TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin alleviates hepatic fibrosis through inducing ferroptosis in hepatic stellate cells.
Zhang Z; Wang X; Wang Z; Zhang Z; Cao Y; Wei Z; Shao J; Chen A; Zhang F; Zheng S
Biofactors; 2021 Sep; 47(5):801-818. PubMed ID: 34129254
[TBL] [Abstract][Full Text] [Related]
10. m
Shen M; Guo M; Li Y; Wang Y; Qiu Y; Shao J; Zhang F; Xu X; Yin G; Wang S; Chen A; Zhang Z; Zheng S
Free Radic Biol Med; 2022 Mar; 182():246-259. PubMed ID: 35248719
[TBL] [Abstract][Full Text] [Related]
11. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand.
Carino A; Biagioli M; Marchianò S; Scarpelli P; Zampella A; Limongelli V; Fiorucci S
Pharmacol Res; 2018 May; 131():17-31. PubMed ID: 29530598
[TBL] [Abstract][Full Text] [Related]
12. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
[TBL] [Abstract][Full Text] [Related]
13. Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells.
Wang F; Jia Y; Li M; Wang L; Shao J; Guo Q; Tan S; Ding H; Chen A; Zhang F; Zheng S
Cell Commun Signal; 2019 Feb; 17(1):11. PubMed ID: 30744642
[TBL] [Abstract][Full Text] [Related]
14. Dihydroartemisinin regulates lipid droplet metabolism in hepatic stellate cells by inhibiting lncRNA-H19-induced AMPK signal.
Xia S; Wang Z; Chen L; Zhou Y; Li Y; Wang S; Chen A; Xu X; Shao J; Zhang Z; Tan S; Zhang F; Zheng S
Biochem Pharmacol; 2021 Oct; 192():114730. PubMed ID: 34400125
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone induction of hepatic stellate cell contraction through activation of RhoA/ROCK-2 signaling pathway.
Ji H; Meng Y; Zhang X; Luo W; Wu P; Xiao B; Zhang Z; Li X
Regul Pept; 2011 Aug; 169(1-3):13-20. PubMed ID: 21545816
[TBL] [Abstract][Full Text] [Related]
16. CXCL12 induces hepatic stellate cell contraction through a calcium-independent pathway.
Saiman Y; Agarwal R; Hickman DA; Fausther M; El-Shamy A; Dranoff JA; Friedman SL; Bansal MB
Am J Physiol Gastrointest Liver Physiol; 2013 Sep; 305(5):G375-82. PubMed ID: 23812037
[TBL] [Abstract][Full Text] [Related]
17. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
Shi Z; Ren M; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
[TBL] [Abstract][Full Text] [Related]
18. The blockade of lipophagy pathway is necessary for docosahexaenoic acid to regulate lipid droplet turnover in hepatic stellate cells.
Qiu S; Xu H; Lin Z; Liu F; Tan F
Biomed Pharmacother; 2019 Jan; 109():1841-1850. PubMed ID: 30551439
[TBL] [Abstract][Full Text] [Related]
19. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
20. Essential roles of sphingosine 1-phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation.
Liu X; Yue S; Li C; Yang L; You H; Li L
J Cell Physiol; 2011 Sep; 226(9):2370-7. PubMed ID: 21660960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
